Dexcom Inc. logo

Dexcom Inc. (DXCM)

Market Open
11 Dec, 16:30
NASDAQ (NGS) NASDAQ (NGS)
$
67. 92
+0.36
+0.53%
$
24.46B Market Cap
134.71 P/E Ratio
0% Div Yield
72,401 Volume
1.43 Eps
$ 67.56
Previous Close
Day Range
67.54 68.92
Year Range
54.11 93.25
Want to track DXCM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 63 days
DXCM INVESTOR ALERT: If You Suffered Losses on Your DexCom, Inc. Investment, Contact BFA Law Before Upcoming October 21 Class Action Deadline

DXCM INVESTOR ALERT: If You Suffered Losses on Your DexCom, Inc. Investment, Contact BFA Law Before Upcoming October 21 Class Action Deadline

NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ:DXCM) and certain of the Company's senior executives. If you invested in DexCom, you are encouraged to obtain additional information by visiting Click Here

Accesswire | 1 year ago
DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

NEW YORK, NY / ACCESSWIRE / September 11, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM

NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Accesswire | 1 year ago
Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - DXCM

Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - DXCM

NEW YORK, NY / ACCESSWIRE / September 11, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Shareholders that Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class Action - DXCM

Shareholders that Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class Action - DXCM

NEW YORK, NY / ACCESSWIRE / September 11, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
DexCom (DXCM) Faces Investor Backlash After Disappointing Earnings Report - Hagens Berman

DexCom (DXCM) Faces Investor Backlash After Disappointing Earnings Report - Hagens Berman

SAN FRANCISCO, CA / ACCESSWIRE / September 11, 2024 / Hagens Berman urges DexCom, Inc. (NASDAQ:DXCM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

Accesswire | 1 year ago
DexCom Inc Is Being Sued For Possibly Committing Securities Fraud And The Schall Law Firm Urges Investors To Reach Out

DexCom Inc Is Being Sued For Possibly Committing Securities Fraud And The Schall Law Firm Urges Investors To Reach Out

LOS ANGELES, CA / ACCESSWIRE / September 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "the Company") (NASDAQ:DXCM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 8, 2024 and July 25, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 21, 2024.

Accesswire | 1 year ago
Class Action Filed Against DexCom, Inc. (DXCM) - October 21, 2024 Deadline to Join - Contact Levi & Korsinsky

Class Action Filed Against DexCom, Inc. (DXCM) - October 21, 2024 Deadline to Join - Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / September 11, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Shareholders that lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM

Shareholders that lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM

NEW YORK, NY / ACCESSWIRE / September 11, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / September 11, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or "the Company") (NASDAQ:DXCM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired DexCom securities between January 8, 2024, and July 25, 2024, inclusive (the "Class Period").

Accesswire | 1 year ago
DexCom, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights – DXCM

DexCom, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights – DXCM

NEW YORK, NY / ACCESSWIRE / September 10, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
October 21, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against DXCM

October 21, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against DXCM

NEW YORK, NY / ACCESSWIRE / September 10, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Loading...
Load More